These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10662962)

  • 1. The role of emission tomography in dementia.
    Perani D
    Ital J Neurol Sci; 1999; 20(5 Suppl):S254-7. PubMed ID: 10662962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of neocortical metabolism predicts progression in Alzheimer's disease.
    Herholz K; Nordberg A; Salmon E; Perani D; Kessler J; Mielke R; Halber M; Jelic V; Almkvist O; Collette F; Alberoni M; Kennedy A; Hasselbalch S; Fazio F; Heiss WD
    Dement Geriatr Cogn Disord; 1999; 10(6):494-504. PubMed ID: 10559566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
    Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
    Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies.
    Devous MD
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1685-96. PubMed ID: 12458405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
    Döbert N; Pantel J; Frölich L; Hamscho N; Menzel C; Grünwald F
    Dement Geriatr Cogn Disord; 2005; 20(2-3):63-70. PubMed ID: 15908747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.
    Scheltens P; Korf ES
    Curr Opin Neurol; 2000 Aug; 13(4):391-6. PubMed ID: 10970055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular imaging of cerebral blood flow and metabolism with SPET and PET in principal dementias].
    Gerasimou G; Bostantjopoulou S; Gotzamani-Psarrakou A
    Hell J Nucl Med; 2009; 12(1):79-83. PubMed ID: 19330195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
    Mielke R; Heiss WD
    J Neural Transm Suppl; 1998; 53():237-50. PubMed ID: 9700661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia.
    Van Heertum RL; Tikofsky RS
    Semin Nucl Med; 2003 Jan; 33(1):77-85. PubMed ID: 12605358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emission tomography in dementia.
    Pakrasi S; O'Brien JT
    Nucl Med Commun; 2005 Mar; 26(3):189-96. PubMed ID: 15722899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis of dementia with single photon emission computed tomography.
    Jagust WJ; Budinger TF; Reed BR
    Arch Neurol; 1987 Mar; 44(3):258-62. PubMed ID: 3493756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography in the differential diagnosis of organic dementias.
    Heiss WD; Kessler J; Szelies B; Grond M; Fink G; Herholz K
    J Neural Transm Suppl; 1991; 33():13-9. PubMed ID: 1753242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional imaging techniques in the diagnosis of non-Alzheimer dementias.
    Brooks DJ
    J Neural Transm Suppl; 1996; 47():155-67. PubMed ID: 8841963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlates of PET- and SPECT-identified defects in dementia.
    Mayberg HS
    J Clin Psychiatry; 1994 Nov; 55 Suppl():12-21. PubMed ID: 7989290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of SPET imaging in dementia.
    Talbot PR; Testa HJ
    Nucl Med Commun; 1995 Jun; 16(6):425-37. PubMed ID: 7675354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.